Skip to main content
. 2021 May 21;106(8):2171–2186. doi: 10.1210/clinem/dgab361

Table 4.

Estimated changes from baseline in muscle performance and physical function outcomes by treatment arm

Variable Placebo 1 mg/day 5 mg/day 15 mg/day P value (5 mg/day vs Placebo) P value (any effect)
Gait speed in 6-minute walk, m/sec 0.06 (0.02, 0.10) 0.08 (0.04, 0.13) 0.09 (0.05, 0.12) 0.06 (−0.001, 0.12) 0.32 0.71
Unloaded 50m walk gait speed, m/sec 0.06 (−0.01, 0.12) 0.13 (0.05, 0.20) 0.03 (−0.03, 0.09) 0.08 (−0.03, 0.19) 0.52 0.26
Loaded 50m walk gait speed, m/sec 0.05 (−0.02, 0.12) 0.12 (0.03, 0.20) 0.05 (−0.02, 0.12) 0.11 (0.001, 0.22) 0.93 0.44
Unloaded stair climb power, watts 7.2 (−35.2, 49.5) 26.6 (−26.1, 79.2) 0.14 (−40.5, 40.7) 45.0 (−26.8, 116.9) 0.80 0.65
Loaded stair climb power, watts 10.9 (−31.7, 53.5) −6.6 (−59.2, 45.9) −6.8 (−54.1, 40.6) 72.2 (2.99, 141.4) 0.56 0.25
Leg press 1-RM, N 7.5 (−87.9, 102.9) 138.6 (17.9, 259.3) 55.6 (−28.0, 139.2) 98.9 (−35.6, 233.5) 0.44 0.30

The data are point estimates and 95% CIs extracted from mixed model framework. P values for overall and for prespecified comparison of 5-mg vs placebo.

Abbreviation: 1-RM, one repetition maximum in Newtons.